Clinical Research Directory
Browse clinical research sites, groups, and studies.
Cryptococcosis Associated With Bruton Tyrosine Kinase Inhibitors
Sponsor: Assistance Publique - Hôpitaux de Paris
Summary
The purpose of this study is to describe the clinical, biological, and radiographic characteristics at the time of cryptococcosis diagnosis, as well as the time interval between the initiation of BTK inhibitor therapy and the diagnosis of cryptococcosis. And also, the clinical course of each patient at 12 months in order to evaluate the susceptibility to cryptococcosis correlated with BTK inhibitor therapy.
Official title: Clinical Features and Outcomes of Cryptococcosis Associated With Bruton Tyrosine Kinase Inhibitors: A Multicenter Retrospective Study
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
OBSERVATIONAL
Enrollment
30
Start Date
2026-10
Completion Date
2027-08
Last Updated
2026-10-19
Healthy Volunteers
No
Conditions
Locations (1)
Hôpital Necker - Enfants Malades
Paris, Paris, France